Search results
GSK Gears Up for Q4 Earnings: Will It Surpass Estimates?
Zacks via Yahoo Finance· 3 months agoWe expect GSK plc. GSK to beat expectations when it reports fourth-quarter and full-year 2023...
COPD Doesn’t Have To Hold You Back – Here’s What To Do After Being Diagnosed
Parade via Yahoo News· 6 months agoMore than 15 million people in the U.S. are affected by COPD (chronic obstructive pulmonary...
Theravance's (TBPH) Q2 Earnings Beat, Focus on Pipeline
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma, Inc. TBPH reported adjusted loss (excluding restructuring and related...
Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 2 months agoIt has been about a month since the last earnings report for GSK (GSK). Shares have added about 3.1%...
Entasis (ETTX) Stock Rises on Buyout Offer From Innoviva
Zacks via Yahoo Finance· 2 years agoEntasis Therapeutics Holdings Inc. ETTX announced that it has signed a definitive merger agreement...
GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance
Zacks via Yahoo Finance· 2 weeks agoGSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The...
GSK Gears Up to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoGSK plc. GSK will report fourth-quarter 2022 results on Feb 1, before the opening bell. In the last...
GSK Beats on Q1 Earnings, Lags Sales, Reaffirms 2023 Outlook
Zacks via Yahoo Finance· 1 year agoThough GSK's revenues benefit from strong growth across all segments, the declining COVID-19...
GSK's Q2 Earnings Beat, Sales Miss, Raises 2022 Guidance
Zacks via Yahoo Finance· 2 years agoGSK's (GSK) revenues benefit from the strong growth in sales across all segments. The company raises...
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
Zacks via Yahoo Finance· 1 year agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive...